Guardant Health Inc. Common Stock vs Viasat — how do they compare? Guardant Health Inc. Common Stock trades at $165.58 (market cap $22.58B), while Viasat trades at $69.07 (market cap $9.76B). The key difference: Guardant Health Inc. Common Stock is far larger — about 2.3× Viasat's market cap, and Guardant Health Inc. Common Stock is trading nearer its 52-week high, Viasat nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 0 Days and Viasat for 10 Days on average.
| GH | VSAT | |
|---|---|---|
Market Cap | $22.58B | $9.76B |
Volume | 2,200,599 | 1,739,997 |
Sector | Health | Technology |
52-Week High | $187.22 | $89.81 |
52-Week Low | $61.73 | $30.35 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $23.22B | $14.95B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →Viasat provides satellite communications and connectivity services for aviation, maritime, government, enterprise, and consumer markets. Its network combines satellite and ground infrastructure to deliver connectivity in remote and mobile environments.
Read more on VSAT →